Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Everest Medicines Announces Successful Release of First Clinical Batch of Tumor-Associated Antigen Vaccine EVM14 at Jiashan Manufacturing Site 2025-06-20 20:09
The Department of Health - Abu Dhabi and Abbot Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi 2025-06-20 16:00
The Department of Health - Abu Dhabi and Sanofi Forge Strategic Alliance to Accelerate the Development of New Global Vaccines in Abu Dhabi 2025-06-19 16:00
Immuno Cure and PharmaJet Announce Collaboration to Advance a Novel HIV Therapeutic DNA Vaccine Using Needle-Free Technology in Humans 2025-06-19 14:11
LOTTE BIOLOGICS Signs Antibody Manufacturing Contract with Ottimo Pharma 2025-06-19 07:00
Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB) 2025-06-18 22:00
RemeGen's Telitacicept (RC18) Received Orphan Drug Designation from EMA for Myasthenia Gravis 2025-06-17 23:16
International Pharmaceuticals, Inc. Partners with Anchanto to Power E-commerce Operations in the Philippines 2025-06-17 11:07
A Decade of Persistent Steps, Aspiring for a Thousand Miles: Qyuns' Grand 10th Anniversary Celebration Held Successfully 2025-06-16 21:14
Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology 2025-06-16 16:00
Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241 2025-06-16 16:00
The 4th Edition of AMSC Malaysia Returns in 2025: Uniting Global Leaders in Aesthetic Medicine, Dermatology, and Surgery 2025-06-16 11:30
Abbisko Therapeutics Completes First Patient Dosing in Registrational Study of Irpagratinib for HCC 2025-06-16 10:47
ArkBio's New Drug Application for ADHD Therapeutic Azstarys Accepted and Granted Priority Review by China NMPA 2025-06-16 09:00
Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels 2025-06-13 19:59
Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases 2025-06-12 21:17
Reacta Healthcare announces transformation into a facility for multi-allergen manufacturing 2025-06-12 19:06
Kelun-Biotech Announces Breakthrough Therapy Designation Granted for Sacituzumab Tirumotecan (Sac-TMT) in Combination With Tagitanlimab in China for Certain Types of Non-Small Cell Lung Cancer 2025-06-11 11:34
Results from Phase 1/2 Study of Kelun-Biotech's TROP2 ADC Sacituzumab Tirumotecan (sac-TMT) in Patients with Unresectable Locally Advanced or Metastatic Solid Tumors Refractory to Standard Therapies, Published in Journal of Hematology & Oncology 2025-06-10 23:52
Linical Celebrates 20 Years of Advancing Clinical Research and Patient Wellbeing 2025-06-10 09:00
1 14 15 16 17 18 280